Cite
HARVARD Citation
Blokland, S. et al. (2019). Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?. RMD open. 5 (1), p. . [Online].